Jellin-Neomycin

Neomycin Sulfate and Fluocinolone Acetonide, the active ingredient in Jellin-Neomycin, is an antibiotic and corticosteroid presented as a topical formulation for skin use. It treats inflammatory and bacterial skin conditions such as dermatitis, eczema, and superficial infections in adults and children.

GNH USA supplies Jellin‑Neomycin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Jellin‑Neomycin is a combined topical antibiotic and anti‑inflammatory used for a range of dermatologic conditions.

Dermatitis: reduces inflammation and bacterial colonisation, improving skin integrity. Eczema: alleviates itching, redness and secondary infection risk. Inflammatory skin conditions: suppresses cytokine production and relieves swelling. Superficial bacterial skin infections: eradicates susceptible bacteria while controlling local inflammation.

Adverse reactions are generally limited to the application site, but systemic effects can occur rarely.

Common Side Effects: - Mild burning or stinging sensation - Local itching or pruritus - Redness or erythema at the application site - Dryness or flaking of the skin - Slight peeling or scaling - Mild irritation with prolonged use

Serious or Rare Side Effects: - Allergic contact dermatitis with vesiculation - Severe skin ulceration or necrosis - Systemic hypersensitivity reactions (e.g., urticaria, angioedema) - Secondary infection due to over‑suppression of local immunity - Adrenal axis suppression with extensive use - Rare ototoxicity if absorbed in large amounts

Before using Jellin‑Neomycin, consider the following safety measures.

Avoid use on broken skin: limit application to intact epidermis. Do not apply to viral, fungal or herpetic lesions: risk of worsening infection. Limit duration of treatment: prolonged use may increase risk of skin atrophy. Use with caution in patients with known hypersensitivity to neomycin or corticosteroids. Pregnancy and lactation: consult a healthcare professional before use. Store at room temperature: keep in the original container, protect from moisture and light.

Jellin‑Neomycin may interact with other medicines; monitor patients accordingly.

Major Interactions (Avoid): - Systemic aminoglycosides: additive ototoxicity or nephrotoxicity. - Concurrent topical corticosteroids: increased risk of systemic absorption and skin thinning. - Live vaccines applied near the site: possible local immune suppression.

Moderate Interactions (Monitor Closely): - Topical antifungal agents: may reduce antifungal efficacy. - Systemic immunosuppressants: heightened infection risk. - Skin care products containing alcohol or strong irritants: may exacerbate local irritation.